Lussac-Sorton, F.; Fleur, T.; Voisin, T.; Issa, N.; Blanchard, É.; Charpentier, É.; Delhaes, L.
Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria. J. Clin. Med. 2023, 12, 316.
https://doi.org/10.3390/jcm12010316
AMA Style
Lussac-Sorton F, Fleur T, Voisin T, Issa N, Blanchard É, Charpentier É, Delhaes L.
Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria. Journal of Clinical Medicine. 2023; 12(1):316.
https://doi.org/10.3390/jcm12010316
Chicago/Turabian Style
Lussac-Sorton, Florian, Tara Fleur, Thibault Voisin, Nahéma Issa, Élodie Blanchard, Éléna Charpentier, and Laurence Delhaes.
2023. "Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria" Journal of Clinical Medicine 12, no. 1: 316.
https://doi.org/10.3390/jcm12010316
APA Style
Lussac-Sorton, F., Fleur, T., Voisin, T., Issa, N., Blanchard, É., Charpentier, É., & Delhaes, L.
(2023). Interest of a Commercialized Pneumocystis jirovecii Quantitative PCR to Discriminate Colonization from Pneumocystis Pneumonia according to the Revised EORTC/MSGERC Criteria. Journal of Clinical Medicine, 12(1), 316.
https://doi.org/10.3390/jcm12010316
